Tag Archive for: improved patient care

cliexa, Integrated Virtual Care Solutions, Announces the Appointment of Robin Linker, CHC, CHCA, CPC-I, CCS-P, COC, MCS-P as an Advisory Board Member.

Robin is a leading expert in health care coding, auditing, education, and documentation nationwide. She is currently the Executive Director of Operations for the Association of Health Care Auditors and Educators and CEO of Robin Linker & Associates, a nationally known healthcare consulting firm in Colorado.

With over 30 years in healthcare, Robin provides consulting, auditing, research, and education in most areas of practice management, compliance and correct coding for teaching institutions and other large facilities to small group or single physician practices. She is credentialed through AHIMA and AAPC in both physician and facility coding, is dually certified in medical compliance, including the Health Care Compliance Association (HCCA); and is a licensed instructor for AAPC and AHCAE. Robin is an author and trainer for the American Medical Association (AMA), and is triple certified in professional (physician), surgical, and risk auditing.

 

“I was thrilled to see the cliexa platform in action and couldn’t wait to tell my clients. Finally, an innovative solution to help our physicians digitally navigate real-time, while allowing patient participation for a scientifically evident, collaborative care approach. What could be better? Coupling patient care first while meeting highly regulated healthcare rules, cliexa has the capability to assist physicians in meeting both coding and documentation standards for a compliant medical record. This promotes accurate charge capture and reimbursement, while reducing risk of audit failure. I am honored to be a part of the cliexa Advisory Board and remain amazed at the continuous advancement of the solution based, cliexa platforms.” –Robin Linker

 

Robin will be providing excessive guidance on quality and compliance for cliexa’s core integrated care solutions that will adapt to multiple subspecialties as it will scale the platform to larger health systems.

 

“The Cliexa team is excited with the addition of Robin to our Advisory Board.  Robin’s broad experience in billing, coding, compliance and practice operations enhance our strong team with a wealth of experience, knowledge and insights.  Digital health is reframing the backend of healthcare, and cliexa is proactively amplifying our internal bench-strength to keep us on the leading edge of this transformation”.  –Dr. Gerald Maccioli, cliexa Advisory Board Chair

how is remote patient monitoring changing the game

Remote patient monitoring is a game changer during the COVID-19 outbreak.

Many questions have been brought up regarding the status of our current healthcare system. How can I get in touch with my physician? How are healthcare clinics handling social distancing and quarantine? Are they still able to meet with me? Do I have any symptoms of Coronavirus? How do I know whether I need to go to a hospital for testing?

Over the last few weeks, our healthcare environment has turned upside down by the emergence of Coronavirus in the United States. Serving patients during this time presents new challenges and has established a “new normal” for clinical workflows.

What exactly is Remote Patient Monitoring (RPM)?

Imagine you are experiencing some symptoms that you’d like your clinician to know about. Maybe you have some preexisting healthcare conditions that make you concerned. Remote patient monitoring allows your clinician to monitor your symptoms and reach out with any changes you should make to your current treatment plan. Most RPM platforms are online or through a mobile application that allow for secure communication with your healthcare provider from the comfort of your home.

cliexa utilizes Remote Patient Monitoring to improve patient care. The platform provides clinically validated assessments with automated disease activity scores, allowing clinicians to tap into wearable devices for real-time data. These wearables provide actionable data that otherwise could go undetected through general patient reported outcomes. This way of closely monitoring patients can lead to an improved patient satisfaction with overall care.

How can Remote Patient Monitoring help during the COVID-19 outbreak?

Remote patient monitoring with cliexa is changing the game in healthcare. Recently, many digital health companies have been working towards telehealth solutions for clinics. With cliexa’s remote patient monitoring, patients do not need to be physically present to onboard. Instead, they can receive care and information from a clinician with a fully remote platform. cliexa addresses the needs of each clinic’s specific Coronavirus response. cliexa enables remote check-in, customized clinical intake, secure transfer of medical history records, and remote patient monitoring. All of these functionalities in the platform seamlessly integrate into the existing EMR system. These functions allow patients to conduct all necessary actions from home on their mobile phones prior to telehealth or in-person visits.

Providers can leverage these services, along with cliexa’s COVID-19 screening, to triage patients with chronic conditions based on their risk level. The cliexa COVID-19 screening capabilities follow the CDC’s guidelines to assess risk factors for patients, including preexisting medical conditions. cliexa allows clinicians to utilize virtual health functionalities including remote monitoring and telemedicine visits.

How does Remote Patient Monitoring differ from Telehealth?

Telehealth allows for physicians to meet with their patients virtually – through video or audio communications. However, telehealth requires that patients have previously gone through an onboarding process with their specific clinic or physician. Many telehealth services still require patients to visit their healthcare provider’s office in-person for onboarding. During this initial office visit, the patient fills out onboarding documentation including waivers and past medical history documents. After all patient information is entered into the clinic’s EMR, only then can the patient enroll in telehealth functionalities.

This is where cliexa’s remote patient monitoring platform differs. Our platform eliminates this step completely. Clinics fully digitize the onboarding process and customize it to their specific clinic needs with cliexa. With remote check-in and customized clinical intake features, patients can enroll with a clinic of their choice and start using telehealth services safely from home. This eliminates the need for an initial in-person visit with a healthcare provider, reducing COVID-19 exposure in hospitals and clinics.

How can I learn more?

During this chaotic time, it’s important to stay informed with what’s happening in our current healthcare system. Using remote patient monitoring in healthcare today is outlined in online articles released almost daily. Participate in webinars to learn more about what digital healthcare companies are doing to help – and review materials like this on your own.

cliexa is determined to do all we can to help healthcare providers overcome challenges and promote better care for patients. To support our healthcare partners through this pandemic, we are waiving all implementation fees until further notice. COVID-19 has distanced us, but with the right tools the show can and must go on.

For more information, check out our brief explainer video or schedule a demo of the cliexa platform with our team here.

tracking the spread of COVID-19

The news of Coronavirus skyrocketing in China peaked during the month of January. At this time, the virus seemed so far away from our reality. Quickly, the virus has spread across the world. The testing for COVID-19 has become more advanced by the week and every day we see hundreds if not thousands more confirmed cases. Track the spread of COVID-19 here.

What can we do to prevent the spread of COVID-19?

As a healthy young individual, the most effective thing you can do is stay home and prevent the spread of this potentially deadly virus. Each citizen plays a large role in spreading the virus to others. The American population who are elderly or immunocompromised are at a higher risk for developing symptoms of the COVID-19 virus. Because of this, ALL citizens are at risk of spreading the virus and should take the quarantine seriously.

The CDC’s guidelines for how to prevent the spread of COVID-19 are conservative at this point. Wash your hands frequently and stay away from densely populated areas. This includes restaurants, bars, and stores. To bolster the prevention of the virus, counties in the San Francisco Bay area have placed a “shelter in place” order. Preventative measures like this will likely spread to other large cities in the coming days.

An important resource to note is the CDC’s guidelines for assessing risk in citizens that have potential exposure to the virus. Be sure to know the signs and symptoms of the virus and utilize any local drive-thru testing centers. Many hospitals are allowing at-risk citizens to call their hotline for remote screening of COVID-19. It’s important for citizens to stay up-to-date on recent news and be prepared to stay home in the coming weeks. As the spread of COVID-19 continues to ramp up in the US, it will be important that everyone does their part.

Work from home, avoid crowded areas, and prepare to stay home for at least the next three weeks. Preventing this virus starts with each individual making a choice to change their lifestyle for the better of their communities. The reason that China was able to reduce the spreading of COVID-19 is because they were willing to effectively quarantine.

How can we track the spread of COVID-19 more effectively?

Testing in the United States is slowly climbing. But, because of limited testing kits across the country, hospitals are being sure to utilize tests on only higher-risk citizens. As of now, people who have not been in direct contact with a confirmed case of Coronavirus are considered low-risk. However, citizens living in densely populated areas with high contact should assume that they have been exposed to the virus. Even if they are not tested, low-risk citizens should take all the same precautions as high-risk individuals to decrease the spread of COVID-19.

Digital healthcare technologies have been integral in tracking COVID-19. Here is how some tech companies are helping to control the spread of the virus. cliexa has incorporated the CDC’s risk assessment guidelines into a platform that can compile data and assess the risk of each patient that is worried about their exposure. This platform provides patient-reported data on risk and symptoms to physicians. This helps healthcare professionals better manage the amount of exposure cases across the nation. We are offering free demos of this platform. You can visit our contact page to schedule a time with our team to learn about the COVID-19 screening application offered through the cliexa platform.

 

cliexa CEO featured in #AskTheCEO podcast

cliexa’s CEO & Founder, Mehmet Kazgan, is featured in the #AskTheCEO Podcast! The #AskTheCEO Podcast host is Avrohom Gottheil, CEO of #AskTheCEO Media.

In this #AskTheCEO episode, Mehmet and Avrohom sit down and discuss the importance of artificial intelligence in healthcare. During the conversation, the two talk about the importance of utilizing innovative technology. This technology is essential in order to stay at the forefront of patient care. As diseases and viruses continue to evolve over time, new healthcare technologies give rise to revolutionary developments. Data collection and AI capabilities are now moving at a pace to evolve and keep up with new diseases and viruses around the world. It is up to the healthcare industry to utilize tools like cliexa in order to compile data and start improving patient outcomes.

cliexa allows for efficient tracking of data, allowing physicians to compile information and make better, more informed decisions on patient treatment plans. This is based on patient outcomes, symptoms, and treatment plans over time. This way, physicians can collect data on what treatments are more effective than others. They can also track patient medication management

Through AI capabilities, cliexa can help to predict optimized treatment plans based on past data collected. Now that cliexa is available on the Azure Marketplace, more physicians and healthcare systems can implement this technology. The Azure Marketplace offers digital platforms to improve healthcare efficiency for users. To learn more about cliexa’s capabilities and how they can benefit patients, physicians, and payors, contact us to schedule a demo here.

 

 

 

Researchers Receive $1 Million Grant to Study Digital Screening Intervention Tool for Adolescents and Young Adults

cliexa is excited to partner with the University of Northern Colorado (UNC) with a grant from the Department of Health and Human Services’ Office of Adolescent Health that provides nearly one million dollars over the next two years for the implementation of cliexa-OPTIONS, a digital screening intervention tool that fosters earlier identification of high-risk adolescents in a clinical setting. The funding supports independent evaluation including, cost-benefit analysis and randomized controlled trial of the cliexa-OPTIONS risk screening tool and MyPLAN mobile health follow-up. The Principal Investigator for the project at UNC is Dr. William Merchant. He is the evaluation professor in the Applied Statistics and Research Methods program in the College of Education and Behavioral Sciences. 

The cost-benefit analysis assesses cost savings between the cliexa-OPTIONS risk screening against current paper pencil and verbal screenings. Also, the cliexa-OPTIONS risk screening identifies 30- 50% more risk in adolescent populations fostering early identification of adolescents at highest risk for acquiring an STI or experiencing an unplanned pregnancy. Improving quality in clinical workflows for adolescent and young adult populations is timely, given that sexually transmitted infections for young people ages 15 -24 are at epidemic proportions.

Saving time and keeping providers satisfied with new technology in clinical workflows is no simple task. The cost-benefit analysis will also assess the benefits of early identification of adolescents at highest risk for adverse reproductive health outcomes, substance use, mental health, and wellness.

Read the full article at: //www.unco.edu/news/newsroom/releases/million-dollar-grant-digital-screening-intervention-tool.aspx